Most patients who have been offered colorectal cancer screening but turned it down are willing to undergo CT colonography as long as out-of-pocket fees are reasonable, according to a study.
Most patients who have been offered colorectal cancer screening but turned it down are willing to undergo CT colonography as long as out-of-pocket fees are reasonable, according to a study.
Of 68 patients who participated in the questionnaire, 83% said they would be willing to undergo CT colonography. However, 70% said they would not be willing to pay out-of-pocket fees if insurance did not cover the study. Among the 30% who said they would pay the fees, the average amount they were willing to pay (mean: $244, median: $150) was well below currently charged rates (AJR 2010;195:393-397).
Although the values may have been influenced by the study's small size, the values are consistent with the cost-effectiveness analysis by the Agency for Healthcare Research and Quality performed for CMS, the authors wrote. CMS found CT colonography could become a cost-effective screening strategy if its cost were $200 or less.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.